Notable, in the Dallas Heart Study, involving 2442 participants without prior cardiovascular disease soluble ESAM, but not soluble ICAM‐1 or soluble VCAM‐1, levels were associated with incident atherosclerotic and total cardiovascular disease (Ren et al., 2017). This evidence concerns the gene ICAM1 and cardiovascular disorder.